Emilia Arturo: Give Your Hematology Paper a Second Chance
Emilia (Emily) Arturo, Senior Managing Editor of Blood and Blood Global Hematology, shared a post by Blood Journals Portfolio on LinkedIn:
”Have a paper already reviewed and rejected at another reputable hematology, immunology, oroncology journal? Consider submitting the paper and its reviews for a Second Look Rapid Response from one of these Blood Journals.”
Quoting Blood Journals Portfolio’s post:
”Submitting to a top medical journal can be a long process and not getting published can feel like a setback. However, it doesn’t have to be the end of your manuscript’s journey.
The five specialized journals in the Blood Journals portfolio, Blood ICT, Blood RCI, Blood VTH, Blood Neoplasia, and Blood Global Hematology are offering authors a rapid second look. If you have research within the scope of one of these journals, you could get published soon with the backing of the renowned Blood brand. It’s simple:
- Update and submit a manuscript previously submitted to another reputable journal (with reviewer feedback)
- Receive an initial editorial assessment within just 3 business days
- Just 8 weeks from submission to publishing of first edition
Your work deserves to be seen. Learn more here.”
Stay updated with Hemostasis Today.
-
Dec 6, 2025, 18:02ASH25 Day 1: Don’t Miss The Highlights
-
Dec 6, 2025, 15:44Atul Gupta on Where The Healthcare Innovation is Headed
-
Dec 6, 2025, 15:22Nathan White on How Inflammation Contributes to Coagulopathy After Trauma
-
Dec 6, 2025, 15:02Anas Younes on AstraZeneca’s Aims in Blood Cancer to Be Presented at ASH25
-
Dec 6, 2025, 14:08David Alderman: ASH25 is Live
-
Dec 6, 2025, 13:53Isabelle Mahé Presents The Proposals from INNOVTE CAT Working Group
-
Dec 6, 2025, 11:50Steve Tuplin on Roche’s Mission at ASH25
-
Dec 6, 2025, 11:13Khaled Musallam on The Lancet Haematology Podcast: Your ASH25 Roadmap
-
Dec 5, 2025, 03:46Sreeni Sivan Pillai: Preventing Thrombophlebitis and Upper Limb DVT in PICC Lines